Lazard Asset Management
VIR icon

Lazard Asset Management’s Vir Biotechnology VIR Stock Holding History

Lazard Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,799
Closed -$16K – 2486
2023
Q3 		$16K Buy
1,799
+542
+43% +$7.73K ﹤0.01% 2124
2023
Q2 		$30K Sell
1,257
-3,314
-73% -$83.2K ﹤0.01% 2004
2023
Q1 		$106K Buy
4,571
+214
+5% +$5.47K ﹤0.01% 1512
2022
Q4 		$110K Buy
+4,357
New +$107K ﹤0.01% 1496
2022
Q3 		– Sell
-3,943
Closed -$100K – 2569
2022
Q2 		$100K Buy
3,943
+280
+8% +$6.54K ﹤0.01% 1508
2022
Q1 		$94K Buy
3,663
+3,631
+11,347% +$108K ﹤0.01% 1421
2021
Q4 		$1K Sell
32
-1,218
-97% -$47.7K ﹤0.01% 2259
2021
Q3 		$54K Buy
+1,250
New +$54.1K ﹤0.01% 1656
2020
Q4 		– Sell
-242
Closed -$8K – 1997
2020
Q3 		$8K Buy
+242
New +$10.4K ﹤0.01% 1505

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return